This is a promotional website intended for UK Healthcare Professionals (HCPs) only.

Prescribing information and adverse event reporting information can be found below.

Valneva
Product

IXCHIQ®powder and solvent for solution for injection. Chikungunya vaccine (live).

IXCHIQ® is a live vaccine licensed to help prevent chikungunya.1 It is indicated in the UK for active immunisation for the prevention of disease caused by CHIKV in individuals 18 years and older.1

View Prescribing InformationFurther information on SMPC Further information on PIL

Place an order

References

  1. IXCHIQ. Summary of Product Characteristics. March 2025. Available at: www.medicines.org.uk/emc/product/100652/smpc. (Accessed June 2025).

Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Valneva UK Ltd Medical Information department on Tel: 01506 446608 or via email: safety@valneva.com

2026 - Please use a modern browser